Titan Pharmaceuticals Inc (TTNP) — Capital Reinvestment Ratio
Titan Pharmaceuticals Inc (TTNP) has a Capital Reinvestment Ratio of 0.00x as of June 2016, meaning it reinvests 0% of its operating cash flow ($13.51 Million) in capital expenditures ($9.00K). See debt-free asset ratio of Titan Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Titan Pharmaceuticals Inc Capital Reinvestment Ratio (1997–2016)
This chart tracks Titan Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Check Titan Pharmaceuticals Inc (TTNP) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year Capital Reinvestment Ratio for Titan Pharmaceuticals Inc from 1997 to 2016. For live market cap and broader valuation context, see Titan Pharmaceuticals Inc (TTNP) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $6.29 Million | $171.00K | ▼ -95.7% |
| 2012 | 0.63x | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $7.10 Million | $100.00K | — |